Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy

NCT02569723 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Colon Adenocarcinoma

Interventions

DRUG: Carbon C 14 Oxaliplatin
DRUG: Oxaliplatin

Sponsor

Edward Kim

Collaborators

[object Object]